fashion -WSS

fashion

author：leisure time 2025-09-06 03:55:25 - browse：4

parts of a dna helix fades while a segment stays solid — Adobe

Flagship Pioneering, the venture capital firm behind Moderna, on Tuesday unveiled a new biotech called Quotient Therapeutics that will have offices in Massachusetts and the United Kingdom.

Quotient, which was founded last year and had operated in stealth mode, wants to develop drugs that target illnesses caused by genetic changes that occur as people age. Those conditions include immune diseases, cancers, neurodegenerative illnesses, and cardiometabolic disorders, such as heart attacks, strokes and diabetes.

With an initial of $50 million from the venture firm Flagship Pioneering, Quotient will be located in Cambridge, Mass., and Cambridge, England. Most of the academic co-founders work in the UK city. Quotient is the first Flagship-backed biotech that will be based in both countries.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： How to keep neuroscience’s past racism from being its future

hotspot

WSS

Steward Health Care files for bankruptcy

Violet CEO on training clinicians to promote more inclusive care

Why health records don't always know when patients are dead

Elevance, private equity launch primary care company

Bristol Myers buys into radiopharmaceuticals with RayzeBio

Prime Medicine, Myeloid Therapeutics clash over genome

knowledge

fashion

entertainment

The high cost of giving birth even with insurance

Can sheer will power keep patients alive in their dying hours?

In age of alternative facts, a scholarly course on calling out crap

Bird flu outbreak in cows is latest avian flu curveball

Jerome Adams on the need for new antivirals for Covid

Violet CEO on training clinicians to promote more inclusive care

The high cost of giving birth even with insurance

Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

Duchenne breakthrough therapy leaves behind pioneering families

It shouldn't be easy to buy synthetic DNA to recreate a deadly virus

hotspot

Readout LOUD podcast: brain research, obesity drug sales, Novartis

Alcohol isn't healthy after all. Will new dietary guidelines reflect that?

Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

Readout Newsletter: Sanofi, Novavax, Maze x Shionogi news

Editas, Vertex strike deal on CRISPR

Software glitch causes Tandem insulin pump to shutdown, FDA warns

explore

explore

hotspot

knowledge